Impact Biomedical

IBONYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$46.913 M

$0.44 -3.48%

Close of 7 Aug 2026

Revenue

$32.0K

#3639 by revenue

Earnings

-$11.8M

Loss-making

Shares outstanding

107,821,231

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#353Filana TherapeuticsFLNA$48.1M
#354Karyopharm TherapeuticsKPTI$48.0M
#355Impact BiomedicalIBO$46.9M
#356Edesa BiotechEDSA$46.9M
#357Mereo BioPharma GroupMREO$46.0M

Where these numbers come from

Share counts and financials for Impact Biomedical are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.